CASI Pharmaceuticals (CASI)

• Market cap: $22.3M
• 1 day: 5.88%
• 5 days: -12.2%
• 1 month: -13.25%
• 3 months: 10.77%
• 6 months: -25.77%
• Year to date: -51.68%
• 1 year: -76.16%
• 5 years: -92.94%
• 10 years: -88.84%
• Sector: Healthcare
• Industry: Biotechnology

About: CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Employees: 233